REALM China Extension Study
NCT02974829 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 4000
Last updated 2016-11-29
Summary
The purpose of this study is to conduct an investigator initiated observational study to continue to follow up the China subset of study participants for another 5 years after they complete participation in the REALM Study
Conditions
- Hepatitis B, Chronic
Interventions
- OTHER
-
follow-up
Sponsors & Collaborators
- collaborator INDUSTRY
-
Nanfang Hospital, Southern Medical University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-05-31
- Primary Completion
- 2022-01-31
Countries
- China
Study Locations
More Related Trials
-
Mother-to-child Transmission of HBV in China
NCT05172453 ·Status: RECRUITING
-
"Real-life" Cohort Study on Patients With Chronic HBV Infection in Jiangsu
NCT03097952 ·Status: RECRUITING
-
Sustained Viral Response in Patients Achieved HBsAg Level≤100 IU/ml After Completed Interferon Treatment
NCT02348502 ·Status: UNKNOWN
-
Comparative Immunogenicity Study of Two Hepatitis A Vaccines
NCT03231605 ·Status: UNKNOWN ·Phase: PHASE4
-
Study on the Optimal Strategy for Acute-on-chronic Liver Failure With Integrative Treatment
NCT03577938 ·Status: COMPLETED ·Phase: NA
-
Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines
NCT02601040 ·Status: COMPLETED ·Phase: PHASE4
-
Rescue Treatment Pattern, Drug Resistance Recurrence, and Direct Medical Costs Associated With Chinese Patients With Chronic Hepatitis B and Drug Resistance to Nucleot(s)Ide Analogue Therapy
NCT02791386 ·Status: COMPLETED
-
Observe Change of Endotoxaemia and Related Mediators in Patients With Chronic Hepatitis B Virus (HBV) Infection
NCT01107483 ·Status: COMPLETED
-
A Cross-sectional Study for Renal Function of Patients With Chronic Hepatitis B in China
NCT04538651 ·Status: UNKNOWN
-
Risk of Hepatitis B Reactivation in Patients With Prior HBV Exposure Undergoing Rituximab-containing Chemotherapy: A Prospective Study
NCT01502397 ·Status: COMPLETED
-
Pharmacogenomics Study on IL28B Genetic Variants in Chinese Children With Hepatitis C Virus Infection
NCT01607021 ·Status: UNKNOWN
-
Immunogenicity and Safety of Hepatitis A Among People Aged 18-50 Years Old
NCT06058416 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
COVID-19 Vaccines in Patients With Chronic Liver Disease
NCT05017805 ·Status: UNKNOWN ·Phase: NA
-
Sustained HBsAg and Viral Response in Patients Achieved HBsAg Loss by Interferon Treatment
NCT02336399 ·Status: UNKNOWN
-
Genes Involved in Resistance or Susceptibility to Hepatitis B Virus
NCT00342186 ·Status: COMPLETED
-
HBsAg Declined Patients Follow-up Study
NCT05977283 ·Status: RECRUITING
-
Study on Gut Microbiota in Chronic HBV Infected Patients
NCT03587467 ·Status: UNKNOWN
-
Immune Dynamics in the Natural History of Chronic HBV Infection
NCT07137247 ·Status: RECRUITING
-
Immunotherapy of Advanced Hepatitis B Related Hepatocellular Carcinoma With γδT Cells
NCT04032392 ·Status: UNKNOWN ·Phase: PHASE1
-
Knowledge and Practice of Chinese Medical Specialists Regarding Chronic Hepatitis B Virus Infection
NCT02511743 ·Status: COMPLETED
-
Safety and Immunogenicity of COVID-19 Vaccine Booster in Patients With Liver Diseases
NCT05204602 ·Status: UNKNOWN
-
A Clinical Trial to Evaluate a Recombinant Hepatitis E Vaccine in Healthy Adults
NCT02603055 ·Status: COMPLETED ·Phase: PHASE1
-
HBsAb Response After HBV Vaccination in Chronic Hepatitis B Patients Who Have Lost HBsAg
NCT03405597 ·Status: UNKNOWN ·Phase: PHASE3
-
Population-wide Research for HBV-related Liver Diseases in Maoming City
NCT06184347 ·Status: NOT_YET_RECRUITING
-
Efficacy of Short-term Immunosuppressive Therapy and Anti-allergenic Therapy in Severe Acute Exacerbation of Chronic Hepatitis B
NCT01627236 ·Status: UNKNOWN ·Phase: NA